Work overview

Section 08 of 11

Ethics Statement

Type III Osteogenesis Imperfecta and COL1A1 Pathological Variants Are Associated With Higher Incidence and Progression of Hearing Loss

Julie A. Christensen, Anne Tran, Hui Cheng, Sara Talvacchio, Carmen C. Brewer, Christopher Zalewski, Jennifer Chisholm, Talah T. Wafa, L. Noelle Allemang, Elena F. Evans, Alberta Derkyi, Joan C. Marini, and Gayla L. Poling · 2026

Contents

Section 08 of 11

  1. 011. Introduction
  2. 022. Materials and Methods
  3. 033. Results
  4. 044. Discussion
  5. 05Author Contributions
  6. 06Funding
  7. 07Disclosure
  8. 08Ethics Statement
  9. 09Conflicts of Interest
  10. 10Supporting Information
  11. 11Supporting information
Text size
Work overview

Section 8 of 11

Ethics Statement

Julie A. Christensen, Anne Tran, Hui Cheng, Sara Talvacchio, Carmen C. Brewer, Christopher Zalewski, Jennifer Chisholm, Talah T. Wafa, L. Noelle Allemang, Elena F. Evans, Alberta Derkyi, Joan C. Marini, and Gayla L. Poling · about 1 minutes

Original source ↗

The Natural History of the Collagen‐Related Disorder Osteogenesis Imperfecta and the Genotype–Phenotype Correlation protocol was approved by the Institutional Review Board of the National Institute of Child Health and Human Development (NICHD). The trial was conducted in accordance with the principles set out in the Declaration of Helsinki. Written informed consent was provided by all participants or parent(s)/legal guardian(s) as required by the IRB.